# BKM120 in Advanced, Metastatic, or Recurrent Endometrial Cancers

> **NCT01550380** · PHASE2 · WITHDRAWN · sponsor: **University of Utah**

## Conditions studied

- Endometrial Cancer

## Interventions

- **DRUG:** BKM120

## Key facts

- **NCT ID:** NCT01550380
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-05
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2014-07-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01550380

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01550380, "BKM120 in Advanced, Metastatic, or Recurrent Endometrial Cancers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01550380. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*